Singular Genomics Systems's market cap is currently ―. The company's EPS TTM is $-1.303; its P/E ratio is -0.39; Singular Genomics Systems is scheduled to report earnings on May 7, 2024, and the estimated EPS forecast is $-0.35. See an overview of income statement, balance sheet, and cash flow financials.

	Dec 23	Sep 23	Jun 23	Mar 23	Dec 22
Income Statement	-
Total Revenue	$ 1.08M	$ 462.00K	$ 505.00K	$ 863.00K	$ 765.00K
Gross Profit	$ -457.00K	$ -65.00K	$ 505.00K	$ 56.00K	$ -1.12M
EBIT	$ -22.96M	$ -22.07M	$ -25.31M	$ -25.38M	$ -22.53M
EBITDA	$ -20.32M	$ -19.43M	$ -23.66M	$ -22.20M	$ -22.13M
Net Income Common Stockholders	$ -23.25M	$ -22.36M	$ -25.58M	$ -23.63M	$ -21.10M
Balance Sheet	-
Cash, Cash Equivalents and Short-Term Investments	$ 173.94M	$ 190.72M	$ 206.68M	$ 226.07M	$ 244.58M
Total Assets	$ 265.47M	$ 284.52M	$ 283.98M	$ 305.47M	$ 327.98M
Total Debt	$ 75.29M	$ 77.00M	$ 58.39M	$ 58.60M	$ 58.84M
Net Debt	$ -98.65M	$ -113.71M	$ -148.29M	$ -167.47M	$ -185.73M
Total Liabilities	$ 86.46M	$ 85.49M	$ 65.59M	$ 65.14M	$ 67.65M
Stockholders Equity	$ 179.01M	$ 199.03M	$ 218.39M	$ 240.32M	$ 260.32M
Cash Flow	-
Free Cash Flow	$ -19.29M	$ -16.92M	$ -20.30M	$ -18.10M	$ -21.73M
Operating Cash Flow	$ -18.90M	$ -16.81M	$ -20.00M	$ -17.93M	$ -19.92M
Investing Cash Flow	$ 651.00K	$ -24.70M	$ -35.09M	$ 72.94M	$ 171.00K
Financing Cash Flow	$ 72.00K	-	$ 618.00K	$ 6.00K	$ 750.00K

Currency in USD

Singular Genomics Systems Earnings and Revenue History

Income Statement >

Singular Genomics Systems Debt to Assets

Balance Sheet >

Singular Genomics Systems Cash Flow

Cash Flow >

Singular Genomics Systems Forecast EPS vs Actual EPS

Earnings >

Get More with TipRanks Premium

What's Included in PREMIUM?

Make informed decisions based on Top Analysts' activity

Know what industry insiders are buying

Get actionable alerts from top Wall Street Analysts

Find out before anyone else which stock is going to shoot up

Get powerful stock screeners & detailed portfolio analysis

Subscribe Now See Plans & Pricing